PCRX vs RZLT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

PCRX

58.6
AI Score
VS
RZLT Wins

RZLT

69.7
AI Score

Investment Advisor Scores

PCRX

59score
Recommendation
HOLD

RZLT

70score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric PCRX RZLT Winner
Forward P/E 6.25 0 Tie
PEG Ratio 11.2121 0 Tie
Revenue Growth 6.2% 0.0% PCRX
Earnings Growth -30.0% 0.0% RZLT
Tradestie Score 58.6/100 69.7/100 RZLT
Profit Margin 2.0% 0.0% PCRX
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

PCRX 1M: -5.2% · 3M: -1.5% RZLT 1M: -12.1% · 3M: -18.7%

Current Technical Phase

PCRX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 50.7 · Price: $25.21

RZLT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.7%), weak momentum, RSI 42

RSI (14): 41.7 · Price: $4.01

Fundamentals Snapshot

Metric PCRX RZLT
Market Cap — —
Forward P/E 7.3 -6.4
Trailing P/E 71.5 —
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.8% —
Operating Margin 0.1% 0.0%
EPS 0.35 -0.75
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, RZLT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.